Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Fennec Pharmaceuticals Inc    FENC   CA31447P1009

FENNEC PHARMACEUTICALS INC (FENC)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 06/21 04:19:33 pm
10.765 USD   -1.69%
06/11Fennec Pharmaceuticals Set to Join Russell 3000 Index
GL
06/08Fennec Announces Results of Annual Meeting
GL
05/14Fennec Provides Business Update and Announces First Quarter 2018 ..
GL
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
06/15/2018 06/18/2018 06/19/2018 06/20/2018 06/21/2018 Date
10.05(c) 10.83(c) 10.96(c) 10.95(c) 10.75 Last
85 164 105 207 100 326 60 455 39 781 Volume
-3.37% +7.76% +1.20% -0.09% -1.83% Change
More quotes
Financials (USD)
Sales 2018 -
EBIT 2018 -7,75 M
Net income 2018 -7,48 M
Debt 2018 -
Yield 2018 -
Sales 2019 48,4 M
EBIT 2019 -9,85 M
Net income 2019 21,8 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019 10,47
Capi. / Sales2018 0
Capi. / Sales2019 4,16x
Capitalization 201 M
More Financials
Company
Fennec Pharmaceuticals, Inc. is a small stage biotechnology company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC. 
More about the company
Latest news on FENNEC PHARMACEUTICALS INC
06/13FENNEC PHARMACEUTICALS INC : Today’s Research Reports on Fennec Pharmaceuticals,..
AC
06/11Fennec Pharmaceuticals Set to Join Russell 3000 Index
GL
06/08Fennec Announces Results of Annual Meeting
GL
05/14Fennec Provides Business Update and Announces First Quarter 2018 Financial Re..
GL
05/02FENNEC PHARMACEUTICALS INC : Today’s Research Reports on Fennec Pharmaceuticals,..
AC
04/02FENNEC PHARMACEUTICALS INC : Today’s Research Reports on Fennec Pharmaceuticals,..
AC
03/27Fennec Pharmaceuticals Receives Breakthrough Therapy Designation by FDA for P..
GL
03/26Fennec Provides Business Update and Announces Fiscal Year Ended December 31, ..
GL
2017Fennec Announces Closing of Public Offering
GL
2017Fennec Announces Pricing of Public Offering
GL
More news
Sector news : Bio Therapeutic Drugs
02:59pGILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
08:02aLatecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/13Sanofi says on track to regain solid position in cancer drugs
RE
06/12GSK says vaccine business president to leave by year-end
RE
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2017Fennec Pharma uplisted to Nasdaq Capital Market today 
2017Fennec Pharmaceuticals (FENCF) Presents At Wedbush PacGrow Healthcare Confere.. 
2017Fennec Pharmaceuticals reports Q2 results 
2017Fennec Pharma completes private $7.6M capital raise 
2017Premarket analyst action - healthcare 
Chart FENNEC PHARMACEUTICALS INC
Duration : Period :
Fennec Pharmaceuticals Inc Technical Analysis Chart | FENC | CA31447P1009 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 19,0 $
Spread / Average Target 73%
EPS Revisions
Managers
NameTitle
Rostislav C. Raykov Chief Executive Officer & Director
Khalid Islam Chairman
Robert C. Andrade Chief Financial Officer
Chris A. Rallis Independent Director
Adrian J. Haigh Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
FENNEC PHARMACEUTICALS INC9.38%201
GILEAD SCIENCES-1.97%89 796
VERTEX PHARMACEUTICALS3.44%38 655
REGENERON PHARMACEUTICALS-16.13%33 439
NEUROCRINE BIOSCIENCES, INC.31.87%9 196
GENMAB-6.69%9 076